1. Homepage
  2. Equities
  3. South Africa
  4. Johannesburg Stock Exchange
  5. Dis-Chem Pharmacies Limited
  6. Summary
    DCP   ZAE000227831

DIS-CHEM PHARMACIES LIMITED

(DCP)
  Report
End-of-day quote Johannesburg Stock Exchange  -  2022-08-14
33.68 ZAR   -0.41%
08/15DIS CHEM PHARMACIES : Dealings in Dis-Chem shares by an associate of a prescribed officer of the Company
PU
07/29DIS CHEM PHARMACIES : Results of the Annual General Meeting
PU
07/14DIS CHEM PHARMACIES : Directorate change
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Johannesburg Stock Exchan…
08/08/2022 08/10/2022 08/11/2022 08/12/2022 08/15/2022 Date
33.51 33.18 34.01 33.82 33.68 Last
258354 528941 663171 264863 128695 Volume
+2.57% -0.98% +2.50% -0.56% -0.41% Change
Estimated financial data (e)
Sales 2023 34 081 M 2 075 M 2 075 M
Net income 2023 1 086 M 66,1 M 66,1 M
Net Debt 2023 1 464 M 89,1 M 89,1 M
P/E ratio 2023 26,2x
Yield 2023 1,51%
Sales 2024 37 624 M 2 290 M 2 290 M
Net income 2024 1 272 M 77,4 M 77,4 M
Net Debt 2024 832 M 50,6 M 50,6 M
P/E ratio 2024 22,6x
Yield 2024 1,75%
Capitalization 28 956 M 1 763 M 1 763 M
EV / Sales 2023 0,89x
EV / Sales 2024 0,79x
Nbr of Employees 20 000
Free-Float 46,9%
More Financials
Company
Dis-Chem Pharmacies Limited is one of the leading distributors of pharmaceutical products in South Africa. The group also distributes personal care, beauty, nutrition, baby care, grocery and household products, and confectionery as well. Net sales break down by activity as follows: - retail sale (89.2%): operating, as of late February 2021, a network of 193 stores located in South Africa (188), Namibia (3) and... 
Sector
Drug Retailers
Calendar
11/02Earnings Release
More about the company
Ratings of Dis-Chem Pharmacies Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D
More Ratings
All news about DIS-CHEM PHARMACIES LIMITED
08/15DIS CHEM PHARMACIES : Dealings in Dis-Chem shares by an associate of a prescribed officer ..
PU
07/29DIS CHEM PHARMACIES : Results of the Annual General Meeting
PU
07/14DIS CHEM PHARMACIES : Directorate change
PU
07/14Dis-Chem Pharmacies Limited Announces Directorate Change
CI
07/07DIS CHEM PHARMACIES : Dealing in Dis-Chem shares pursuant to an employee share scheme
PU
06/30DIS CHEM PHARMACIES : Distribution of Integrated Annual Report, Group and Company Audited ..
PU
05/23Dis-Chem Pharmacies Limited Reports Earnings Results for the Full Year Ended February 2..
CI
05/23TRANSCRIPT : Dis-Chem Pharmacies Limited, 2022 Earnings Call, May 23, 2022
CI
05/23Dis-Chem Pharmacies Limited Declares Final Dividend for the Financial Year 2022
CI
04/28Dis-Chem Chooses Clickatell's Chat Commerce Platform to Serve Millions of Customers Ove..
AQ
04/28Dis-Chem Chooses Clickatell's Chat Commerce Platform to Serve Millions of Customers Ove..
AQ
04/28DIS CHEM PHARMACIES : Trading Statement
PU
04/04DIS CHEM PHARMACIES : Directorate Change to Board Committees
PU
02/14Dis-Chem Pharmacies Limited Announces Group Revenue Results for the 21-Weeks to 26 Janu..
CI
2021Dis-Chem Pharmacies Limited Announces Directorate Change
CI
More news
News in other languages on DIS-CHEM PHARMACIES LIMITED
07/14Dis-Chem Pharmacies Limited annonce un changement de direction
05/23Dis-Chem Pharmacies Limited annonce ses résultats pour l'exercice complet terminé le 28..
05/23Dis-Chem Pharmacies Limited déclare un dividende final pour l'exercice 2022
2021Le bénéfice de Dis-Chem en Afrique du Sud augmente grâce à la reprise de la demande de ..
2021Dis-Chem Pharmacies Limited annonce un dividende pour la période se terminant le 31 aoû..
More news
Chart DIS-CHEM PHARMACIES LIMITED
Duration : Period :
Dis-Chem Pharmacies Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIS-CHEM PHARMACIES LIMITED
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 33,68 ZAR
Average target price 37,30 ZAR
Spread / Average Target 10,7%
EPS Revisions
Managers and Directors
Ivan Leon Saltzman Chief Executive Officer & Executive Director
Rui Manuel Morais Chief Financial Officer & Executive Director
Laurence Michael Nestadt Non-Executive Chairman
Anuschka Coovadia Independent Non-Executive Director
Johannes Sanyana Mthimunye Independent Non-Executive Director
Sector and Competitors